Breaking The Chains Of Conventional Drug Research Models: Why Organ-Chips Can Help Bridge The Translation Gap

Despite significant advancements in research technology over the past few decades, 90% of drug candidates still fail in clinical trials. This substantial translation gap is largely due to the fact that animal models do not accurately predict human response.

Continuing to rely on data from animal models hinders R&D productivity and prevents the development of critical life-saving drugs. It is crucial to shift our focus from curing diseases in animals to curing diseases in humans.

Organ-on-a-Chip technology offers a solution by providing better insight into human response much earlier in the drug development process, paving the way for truly human-centric therapies.

Gain expert insights into the limitations of conventional research models, the reasons why animal models fail to predict human response, and the ways Organ-on-a-Chip technology is helping researchers bridge the translation gap and overcome pervasive barriers in drug development.